Fig. 2 | Scientific Reports

Fig. 2

From: The new bilastine eye drop formulation protects against conjunctival dehydration and promotes corneal wound healing in a comparative in vitro study

Fig. 2

Bioadhesion work (mJ) obtained for each antiallergic ophthalmic formulation using fresh bovine cornea model as a substrate. Results are presented as means ± standard deviations. Asterisks indicate significant differences (p < 0.05) in comparison with EDF 3. EDF 1 (0.025% ketotifen fumarate); EDF 2 (0.05% azelastine hydrochloride); EDF 3 (0.6% bilastine); EDF 4 (0.222% olopatadine hydrochloride); EDF 5 (0.05% azelastine hydrochloride); EDF 6 (0.776% olopatadine hydrochloride); EDF 7 (0.05% levocabastine hydrochloride); EDF 8 (0.1% olopatadine hydrochloride); EDF 9 (0.025% ketotifen fumarate).

Back to article page